Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
European Heart Journal|October 26, 2017
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk scoreZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.Lancet (London, England)|April 9, 2016
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation studyZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.Open Heart|March 20, 2021
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areasTymon Pol, Ziad Hijazi, Johan Lindbäck, et al.Journal of the American College of Cardiology|October 27, 2022
Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary SyndromesGorav Batra, Johan Lindbäck, Richard C Becker, et al.Journal of the American College of Cardiology|March 19, 2025
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial FibrillationLars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.JAMA Network Open|September 16, 2020
Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY TrialsZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.Journal of Thrombosis and Haemostasis : JTH|February 5, 2026
Evaluation of the updated ABC-AF-bleeding score 2.0 in patients with atrial fibrillation treated with a direct oral anticoagulant or warfarinZiad Hijazi, Johan Lindbäck, Jonas Oldgren, et al.American Heart Journal|January 5, 2021
Risk markers of incident atrial fibrillation in patients with coronary heart diseaseMaria Tomasdottir, Claes Held, Nermin Hadziosmanovic, et al.Journal of the American Heart Association|August 19, 2020
Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) TrialIda Gregersen, Annika E Michelsen, Ngoc Nguyen Lunde, et al.Journal of the American College of Cardiology|August 12, 2017
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary DiseaseDaniel Lindholm, Johan Lindbäck, Paul W Armstrong, et al.Pageof 10